Overview

  • Product nameAnti-Mad2L1 antibody
    See all Mad2L1 primary antibodies
  • Description
    Rabbit polyclonal to Mad2L1
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Guinea pig, Cow, Pig, Chimpanzee, Ferret, Baboon, Rhesus monkey, Gorilla, Orangutan
  • Immunogen

    Synthetic peptide, corresponding to a region within amino acids 100-150 of Human Mad2L1 (SwissProt entry Q13257)

  • Positive control
    • human breast carcinoma

Properties

Applications

Our Abpromise guarantee covers the use of ab87274 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P
  • Application notesIHC-P: 1/100 - 1/500. Epitope exposure is recommended.
    Epitope exposure with tris-EDTA pH9.0 buffer will enhance staining.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionComponent of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. Required for the execution of the mitotic checkpoint which monitors the process of kinetochore-spindle attachment and inhibits the activity of the anaphase promoting complex by sequestering CDC20 until all chromosomes are aligned at the metaphase plate.
    • Sequence similaritiesBelongs to the MAD2 family.
      Contains 1 HORMA domain.
    • DomainThe protein has two highly different native conformations, an inactive open conformation that cannot bind CDC20 and that predominates in cytosolic monomers, and an active closed conformation. The protein in the closed conformation preferentially dimerizes with another molecule in the open conformation, but can also form a dimer with a molecule in the closed conformation. Formation of a heterotetrameric core complex containing two molecules of MAD1L1 and of MAD2L1 in the closed conformation promotes binding of another molecule of MAD2L1 in the open conformation and the conversion of the open to the closed form, and thereby promotes interaction with CDC20.
    • Post-translational
      modifications
      Phosphorylated on multiple serine residues. The level of phosphorylation varies during the cell cycle and is highest during mitosis. Phosphorylation abolishes interaction with MAD1L1 and reduces interaction with CDC20.
    • Cellular localizationNucleus. Chromosome > centromere > kinetochore. Cytoplasm. Recruited by MAD1L1 to unattached kinetochores (Probable). Recruited to the nuclear pore complex by TPR during interphase. Recruited to kinetochores in late prometaphase after BUB1, CENPF, BUB1B and CENPE. Kinetochore association requires the presence of NEK2. Kinetochore association is repressed by UBD.
    • Information by UniProt
    • Database links
    • Alternative names
      • HsMAD 2 antibody
      • HsMAD2 antibody
      • MAD 2 antibody
      • MAD 2A antibody
      • MAD2 like 1 antibody
      • MAD2 like protein 1 antibody
      • MAD2 mitotic arrest deficient like 1 antibody
      • MAD2-like protein 1 antibody
      • Mad2l1 antibody
      • MD2L1_HUMAN antibody
      • Mitotic arrest deficient 2-like protein 1 antibody
      • Mitotic arrest deficient yeast homolog like 1 antibody
      • Mitotic spindle assembly checkpoint protein MAD2A antibody
      see all

    Anti-Mad2L1 antibody images

    • Detection of Human Mad2L1 by ab87274 at 1:250 dilution using a Formalin-Fixed Paraffin-Embedded section of human breast carcinoma. Detection by means of DAB staining.

    References for Anti-Mad2L1 antibody (ab87274)

    ab87274 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab87274.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"